PCCA Introduces Innovative New Compounding Base – SuspendIt® Anhydrous Houston, Jan. 11, 2023 (GLOBE NEWSWIRE) -- PCCA’s innovative new oral suspending base, SuspendIt Anhydrous, is ideal for active pharmaceutical ingredients (APIs) that are unstable in water or have...

PCCA Appoints New Chief Financial Officer, Manfredo Thibau, MBA Houston, Oct. 04, 2022 (GLOBE NEWSWIRE) -- PCCA announced today that Manfredo Thibau, MBA, formerly Vice President, Finance, of Vibrantz Technologies, Inc., has joined the company and started his...

PCCA opens registration to all compounders for pharmacy compounding training courses on quality, compliance and regulatory requirements Houston, Texas, July 26, 2022 (GLOBE NEWSWIRE) -- In an effort to ensure quality compounding throughout the industry for all patients, PCCA is opening registration for all compounding pharmacists...

PCCA’s compounding pharmacist members call on Congress to protect patient access to compounded medication Houston, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- Compounding pharmacists nationwide are calling on lawmakers to thwart efforts that pharmacists fear would restrict patient access to compounded...

PCCA Partners with KUNESA to Offer Turnkey Lab Design and Construction Services for Compounding Pharmacies Houston, Texas, April 13, 2022 (GLOBE NEWSWIRE) -- PCCA, a Houston-based, FDA-registered supplier of active pharmaceutical ingredients, excipients and technical consulting to pharmacies, health care...